News - Page 129 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Entheon Biomedical Announces EEG Patent Application & Provides Research Update

Entheon Biomedical Announces EEG Patent Application & Provides Research Update

Post published:December 16, 2021
Post category:Press Release

Read more about the article atai Impact Establishes the atai Fellowship Fund in Psychedelic Neuroscience with Massachusetts General Hospital’s Center for the Neuroscience of Psychedelics

atai Impact Establishes the atai Fellowship Fund in Psychedelic Neuroscience with Massachusetts General Hospital’s Center for the Neuroscience of Psychedelics

Post published:December 16, 2021
Post category:Press Release

Read more about the article Awakn Life Sciences Reports Fiscal Third Quarter 2021 Financial Results and Business Highlights

Awakn Life Sciences Reports Fiscal Third Quarter 2021 Financial Results and Business Highlights

Post published:December 15, 2021
Post category:Press Release

Read more about the article Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office for CYB004 (Deuterated Psychedelic Tryptamine) for the Treatment of Anxiety Disorders

Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office for CYB004 (Deuterated Psychedelic Tryptamine) for the Treatment of Anxiety Disorders

Post published:December 15, 2021
Post category:Press Release

Read more about the article MYND Life Sciences Provides Update on Depression Gene Modulation Pathway Patent Application

MYND Life Sciences Provides Update on Depression Gene Modulation Pathway Patent Application

Post published:December 15, 2021
Post category:Press Release

Read more about the article Apeiron and Other Key Shareholders of atai Life Sciences Reinforce Support by Entering into Extended, Voluntary Share Lock-up Agreements

Apeiron and Other Key Shareholders of atai Life Sciences Reinforce Support by Entering into Extended, Voluntary Share Lock-up Agreements

Post published:December 15, 2021
Post category:Press Release

Read more about the article Psyched Wellness Hires Del Mahabadi as Digital Marketing Consultant to Drive AME-1 Product Launch

Psyched Wellness Hires Del Mahabadi as Digital Marketing Consultant to Drive AME-1 Product Launch

Post published:December 14, 2021
Post category:Press Release

Read more about the article Silo Pharma, Inc. Engages Donohoe Advisory to Assist with its Efforts to Obtain a Listing on a National Stock Exchange

Silo Pharma, Inc. Engages Donohoe Advisory to Assist with its Efforts to Obtain a Listing on a National Stock Exchange

Post published:December 14, 2021
Post category:Press Release

Read more about the article PharmaTher Announces Positive Research Results for LSD Microneedle Patch

PharmaTher Announces Positive Research Results for LSD Microneedle Patch

Post published:December 14, 2021
Post category:Press Release

Read more about the article Awakn Life Sciences Appoints Former EVP & Chief Commercial Officer of Gilead Sciences, Paul Carter, as Independent Member of its Board of Directors

Awakn Life Sciences Appoints Former EVP & Chief Commercial Officer of Gilead Sciences, Paul Carter, as Independent Member of its Board of Directors

Post published:December 14, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.